Healthcare provider profile · identity verified

Thomas V Bilisko, MD

Internal Medicine · WYOMING, MI · NPI 1275537011

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	736	207
Levothyroxine Sodium	Levothyroxine Sodium	570	145
Amlodipine Besylate	Amlodipine Besylate	529	146
Omeprazole	Omeprazole	437	119
Losartan Potassium	Losartan Potassium	377	102
Metoprolol Succinate	Metoprolol Succinate	353	93
Pravastatin Sodium	Pravastatin Sodium	315	94
Simvastatin	Simvastatin	254	69
Rosuvastatin Calcium	Rosuvastatin Calcium	225	71
Lisinopril	Lisinopril	214	58
Metformin Hcl	Metformin Hcl	214	60
Glipizide Er	Glipizide	200	48
Hydrochlorothiazide	Hydrochlorothiazide	197	56
Potassium Chloride	Potassium Chloride	190	60
Gabapentin	Gabapentin	187	58
Irbesartan	Irbesartan	170	50
Eliquis	Apixaban	169	42
Allopurinol	Allopurinol	162	45
Pantoprazole Sodium	Pantoprazole Sodium	161	47
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	151	46
Metformin Hcl Er	Metformin Hcl	147	39
Alprazolam	Alprazolam	139	34
Furosemide	Furosemide	126	45
Sertraline Hcl	Sertraline Hcl	125	37
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	119	30
Albuterol Sulfate Hfa	Albuterol Sulfate	117	51
Tamsulosin Hcl	Tamsulosin Hcl	116	41
Chlorthalidone	Chlorthalidone	114	32
Doxazosin Mesylate	Doxazosin Mesylate	113	31
Carvedilol	Carvedilol	109	33
Trazodone Hcl	Trazodone Hcl	108	32
Zolpidem Tartrate	Zolpidem Tartrate	107	23
Januvia	Sitagliptin Phosphate	103	21
Escitalopram Oxalate	Escitalopram Oxalate	96	24
Citalopram Hbr	Citalopram Hydrobromide	85	21
Duloxetine Hcl	Duloxetine Hcl	85	24
Tramadol Hcl	Tramadol Hcl	85	19
Finasteride	Finasteride	81	21
Fluticasone Propionate	Fluticasone Propionate	77	31
Famotidine	Famotidine	75	24
Bupropion Xl	Bupropion Hcl	73	22
Prednisone	Prednisone	73	36
Memantine Hcl	Memantine Hcl	71	19
Benazepril Hcl	Benazepril Hcl	70	19
Montelukast Sodium	Montelukast Sodium	70	19
Cephalexin	Cephalexin	66	52
Clopidogrel	Clopidogrel Bisulfate	61	18
Atenolol	Atenolol	60	19
Felodipine Er	Felodipine	57	15
Methylprednisolone	Methylprednisolone	57	48
Venlafaxine Hcl Er	Venlafaxine Hcl	57	12
Ezetimibe	Ezetimibe	55	19
Lovastatin	Lovastatin	54	19
Amoxicillin	Amoxicillin	53	44
Repaglinide	Repaglinide	53	12
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	51	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	50	13
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	50	16
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	49	18
Telmisartan	Telmisartan	49	14
Estradiol	Estradiol	48	22
Fluoxetine Hcl	Fluoxetine Hcl	48	14
Lorazepam	Lorazepam	47	18
Metoprolol Tartrate	Metoprolol Tartrate	47	13
Oxycodone Hcl	Oxycodone Hcl	45	12
Azithromycin	Azithromycin	44	40
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	42	suppressed
Methocarbamol	Methocarbamol	41	15
Xarelto	Rivaroxaban	39	11
Valacyclovir	Valacyclovir Hcl	38	18
Lansoprazole	Lansoprazole	37	11
Alfuzosin Hcl Er	Alfuzosin Hcl	36	11
Warfarin Sodium	Warfarin Sodium	36	11
Esomeprazole Magnesium	Esomeprazole Magnesium	34	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	34	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	34	21
Cefuroxime	Cefuroxime Axetil	33	23
Ozempic	Semaglutide	33	suppressed
Jardiance	Empagliflozin	32	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	32	12
Tolterodine Tartrate Er	Tolterodine Tartrate	30	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	29	23
Celecoxib	Celecoxib	27	suppressed
Nifedipine Er	Nifedipine	27	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	27	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	26	24
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	26	suppressed
Levetiracetam	Levetiracetam	25	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	24	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	24	24
Trulicity	Dulaglutide	24	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	23	16
Myrbetriq	Mirabegron	23	suppressed
Propranolol Hcl Er	Propranolol Hcl	23	suppressed
Ramipril	Ramipril	23	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	22	suppressed
Hydralazine Hcl	Hydralazine Hcl	22	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	22	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	22	suppressed
Alendronate Sodium	Alendronate Sodium	21	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	21	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	20	suppressed
Metronidazole	Metronidazole	20	suppressed
Terazosin Hcl	Terazosin Hcl	20	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	20	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	18
Spironolactone	Spironolactone	19	suppressed
Valsartan	Valsartan	18	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	18	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	17	suppressed
Humalog Kwikpen U-100	Insulin Lispro	17	suppressed
Klor-Con M20	Potassium Chloride	17	suppressed
Mirtazapine	Mirtazapine	17	suppressed
Synthroid	Levothyroxine Sodium	17	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	17	suppressed
Tizanidine Hcl	Tizanidine Hcl	17	11
Ventolin Hfa	Albuterol Sulfate	17	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Fenofibrate	Fenofibrate	16	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	15	suppressed
Aripiprazole	Aripiprazole	15	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	15	suppressed
Memantine Hcl Er	Memantine Hcl	15	suppressed
Pregabalin	Pregabalin	15	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Buspirone Hcl	Buspirone Hcl	14	suppressed
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Folic Acid	Folic Acid	14	suppressed
Glipizide	Glipizide	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Teriparatide	Teriparatide	14	suppressed
Verapamil Sr	Verapamil Hcl	14	suppressed
Clobetasol Propionate	Clobetasol Propionate	13	suppressed
Dexlansoprazole Dr	Dexlansoprazole	13	suppressed
Eszopiclone	Eszopiclone	13	suppressed
Glimepiride	Glimepiride	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Fluconazole	Fluconazole	12	suppressed
Methimazole	Methimazole	12	suppressed
Micardis Hct	Telmisartan/Hydrochlorothiazid	12	suppressed
Nystatin	Nystatin	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Trandolapril	Trandolapril	12	suppressed
Victoza 3-Pak	Liraglutide	12	suppressed
Armodafinil	Armodafinil	11	suppressed
Baclofen	Baclofen	11	suppressed
Benzonatate	Benzonatate	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	11	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Mometasone Furoate	Mometasone Furoate	11	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed
Prazosin Hcl	Prazosin Hcl	11	suppressed
Rizatriptan	Rizatriptan Benzoate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error